https://www.clinicalbiostats.com/news/eli-lilly-retatrutide-impressive-results/2023-07-30T17:35:35+00:00https://www.clinicalbiostats.com/news/okyo-pharma-ncp-jp/2023-07-30T17:24:41+00:00https://www.clinicalbiostats.com/news/okyo-pharma-ncp/2023-07-30T17:17:25+00:00https://www.clinicalbiostats.com/news/eli-lilly-retatrudide-results-jp/2023-07-30T17:50:20+00:00https://www.clinicalbiostats.com/news/sumitomo-pharma-and-otsuka-face-challenges-as-ulotaronts-potential-as-a-schizophrenia-treatment-remains-uncertain/2023-08-01T00:59:36+00:00